These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15821465)

  • 1. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence.
    Cohen DD; Matin SF; Steinberg JR; Zagone R; Wood CG
    J Urol; 2005 May; 173(5):1487-90; discussion 1490-1. PubMed ID: 15821465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach and specimen handling do not influence oncological perioperative and long-term outcomes after laparoscopic radical nephrectomy.
    Gabr AH; Gdor Y; Strope SA; Roberts WW; Wolf JS
    J Urol; 2009 Sep; 182(3):874-80. PubMed ID: 19616234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact specimen extraction in laparoscopic nephrectomy procedures: Pfannenstiel versus expanded port site incisions.
    Tisdale BE; Kapoor A; Hussain A; Piercey K; Whelan JP
    Urology; 2007 Feb; 69(2):241-4. PubMed ID: 17320656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    Levy DA; Slaton JW; Swanson DA; Dinney CP
    J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional study on the safety and efficacy of specimen morcellation after laparoscopic radical nephrectomy for clinical stage T1 or T2 renal cell carcinoma.
    Wu SD; Lesani OA; Zhao LC; Johnston WK; Wolf JS; Clayman RV; Nadler RB
    J Endourol; 2009 Sep; 23(9):1513-8. PubMed ID: 19694517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
    Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
    Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of pathological evaluation of morcellated kidneys after radical nephrectomy.
    Landman J; Lento P; Hassen W; Unger P; Waterhouse R
    J Urol; 2000 Dec; 164(6):2086-9. PubMed ID: 11061932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN; Weight CJ; Gill IS
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
    Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
    BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
    Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
    J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of laparoscopic radical nephrectomy with manual specimen morcellation for stage cT1 renal-cell carcinoma.
    Lesani OA; Zhao LC; Han J; Okotie O; Desireddi NV; Johnston WK; Nadler RB
    J Endourol; 2008 Jun; 22(6):1257-9. PubMed ID: 18578659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma.
    Simmons MN; Kaouk J; Gill IS; Fergany A
    Urology; 2007 Jul; 70(1):43-6. PubMed ID: 17656205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery.
    Porpiglia F; Fiori C; Terrone C; Bollito E; Fontana D; Scarpa RM
    J Urol; 2005 Apr; 173(4):1098-101. PubMed ID: 15758709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic and partial nephrectomy.
    Novick AC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6322S-7S. PubMed ID: 15448025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.